First Time Loading...

WAVE Life Sciences Ltd
NASDAQ:WVE

Watchlist Manager
WAVE Life Sciences Ltd Logo
WAVE Life Sciences Ltd
NASDAQ:WVE
Watchlist
Price: 5.01 USD -1.38%
Updated: Apr 25, 2024

Intrinsic Value

WVE's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. [ Read More ]

The intrinsic value of one WVE stock under the Base Case scenario is 3.27 USD. Compared to the current market price of 5.01 USD, WAVE Life Sciences Ltd is Overvalued by 35%.

Key Points:
WVE Intrinsic Value
Base Case
3.27 USD
Overvaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
WAVE Life Sciences Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling WVE stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
WAVE Life Sciences Ltd

Provide an overview of the primary business activities
of WAVE Life Sciences Ltd.

What unique competitive advantages
does WAVE Life Sciences Ltd hold over its rivals?

What risks and challenges
does WAVE Life Sciences Ltd face in the near future?

Has there been any significant insider trading activity
in WAVE Life Sciences Ltd recently?

Summarize the latest earnings call
of WAVE Life Sciences Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for WAVE Life Sciences Ltd.

Provide P/S
for WAVE Life Sciences Ltd.

Provide P/E
for WAVE Life Sciences Ltd.

Provide P/OCF
for WAVE Life Sciences Ltd.

Provide P/FCFE
for WAVE Life Sciences Ltd.

Provide P/B
for WAVE Life Sciences Ltd.

Provide EV/S
for WAVE Life Sciences Ltd.

Provide EV/GP
for WAVE Life Sciences Ltd.

Provide EV/EBITDA
for WAVE Life Sciences Ltd.

Provide EV/EBIT
for WAVE Life Sciences Ltd.

Provide EV/OCF
for WAVE Life Sciences Ltd.

Provide EV/FCFF
for WAVE Life Sciences Ltd.

Provide EV/IC
for WAVE Life Sciences Ltd.

Show me price targets
for WAVE Life Sciences Ltd made by professional analysts.

What are the Revenue projections
for WAVE Life Sciences Ltd?

How accurate were the past Revenue estimates
for WAVE Life Sciences Ltd?

What are the Net Income projections
for WAVE Life Sciences Ltd?

How accurate were the past Net Income estimates
for WAVE Life Sciences Ltd?

What are the EPS projections
for WAVE Life Sciences Ltd?

How accurate were the past EPS estimates
for WAVE Life Sciences Ltd?

What are the EBIT projections
for WAVE Life Sciences Ltd?

How accurate were the past EBIT estimates
for WAVE Life Sciences Ltd?

Compare the revenue forecasts
for WAVE Life Sciences Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of WAVE Life Sciences Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of WAVE Life Sciences Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of WAVE Life Sciences Ltd compared to its peers.

Compare the P/E ratios
of WAVE Life Sciences Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing WAVE Life Sciences Ltd with its peers.

Analyze the financial leverage
of WAVE Life Sciences Ltd compared to its main competitors.

Show all profitability ratios
for WAVE Life Sciences Ltd.

Provide ROE
for WAVE Life Sciences Ltd.

Provide ROA
for WAVE Life Sciences Ltd.

Provide ROIC
for WAVE Life Sciences Ltd.

Provide ROCE
for WAVE Life Sciences Ltd.

Provide Gross Margin
for WAVE Life Sciences Ltd.

Provide Operating Margin
for WAVE Life Sciences Ltd.

Provide Net Margin
for WAVE Life Sciences Ltd.

Provide FCF Margin
for WAVE Life Sciences Ltd.

Show all solvency ratios
for WAVE Life Sciences Ltd.

Provide D/E Ratio
for WAVE Life Sciences Ltd.

Provide D/A Ratio
for WAVE Life Sciences Ltd.

Provide Interest Coverage Ratio
for WAVE Life Sciences Ltd.

Provide Altman Z-Score Ratio
for WAVE Life Sciences Ltd.

Provide Quick Ratio
for WAVE Life Sciences Ltd.

Provide Current Ratio
for WAVE Life Sciences Ltd.

Provide Cash Ratio
for WAVE Life Sciences Ltd.

What is the historical Revenue growth
over the last 5 years for WAVE Life Sciences Ltd?

What is the historical Net Income growth
over the last 5 years for WAVE Life Sciences Ltd?

What is the current Free Cash Flow
of WAVE Life Sciences Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for WAVE Life Sciences Ltd.

Financials

Balance Sheet Decomposition
WAVE Life Sciences Ltd

Current Assets 235.4m
Cash & Short-Term Investments 200.4m
Receivables 21.1m
Other Current Assets 13.9m
Non-Current Assets 39.6m
PP&E 35.7m
Other Non-Current Assets 3.9m
Current Liabilities 186.4m
Accounts Payable 12.8m
Accrued Liabilities 23.5m
Other Current Liabilities 150.1m
Non-Current Liabilities 41m
Other Non-Current Liabilities 41m
Efficiency

Earnings Waterfall
WAVE Life Sciences Ltd

Revenue
113.3m USD
Operating Expenses
-181.3m USD
Operating Income
-68m USD
Other Expenses
10.5m USD
Net Income
-57.5m USD

Free Cash Flow Analysis
WAVE Life Sciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

WVE Profitability Score
Profitability Due Diligence

WAVE Life Sciences Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
ROIC is Increasing
Negative Revenue Growth Forecast
25/100
Profitability
Score

WAVE Life Sciences Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

WVE Solvency Score
Solvency Due Diligence

WAVE Life Sciences Ltd's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
49/100
Solvency
Score

WAVE Life Sciences Ltd's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

WVE Price Targets Summary
WAVE Life Sciences Ltd

Wall Street analysts forecast WVE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WVE is 13.26 USD with a low forecast of 5.05 USD and a high forecast of 19.95 USD.

Lowest
Price Target
5.05 USD
1% Upside
Average
Price Target
13.26 USD
165% Upside
Highest
Price Target
19.95 USD
298% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

WVE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

WVE Price
WAVE Life Sciences Ltd

1M 1M
-13%
6M 6M
-11%
1Y 1Y
+27%
3Y 3Y
-20%
5Y 5Y
-82%
10Y 10Y
-69%
Annual Price Range
5.01
52w Low
3.51
52w High
6.87
Price Metrics
Average Annual Return -9.34%
Standard Deviation of Annual Returns 74.55%
Max Drawdown -97%
Shares Statistics
Market Capitalization 597m USD
Shares Outstanding 122 284 000
Percentage of Shares Shorted 5.31%

WVE Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

WAVE Life Sciences Ltd Logo
WAVE Life Sciences Ltd

Country

Singapore

Industry

Pharmaceuticals

Market Cap

597m USD

Dividend Yield

0%

Description

Wave Life Sciences Ltd. is a biotechnology company, which engages in the development of proprietary synthetic chemistry drug. The company employs 235 full-time employees The company went IPO on 2015-11-11. The firm is developing oligonucleotides, which targets ribonucleic acid (RNA) to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Using PRISM, its own discovery and drug development platform, which enables the precise design, optimization and production of stereopure oligonucleotides, it aspires to develop medicines for genetically defined diseases with a degree of unmet need. By intervening at the RNA level, it has the potential to address diseases with small molecules or biologics, while retaining the ability to titrate dose and avoid permanent off-target genetic changes and other challenges associated with DNA editing or gene therapy approaches.

Contact

7 Straits View, #12-00, Marina One East Tower
+6562363388.0
https://www.wavelifesciences.com/

IPO

2015-11-11

Employees

235

Officers

President, CEO & Director
Dr. Paul B. Bolno M.B.A., M.D.
CFO & Principal Accounting Officer
Mr. Kyle B. Moran CFA
Chief Technology Officer
Dr. Chandra Vargeese Ph.D.
Head of Investor Relations
Kate Rausch
Senior VP & General Counsel
Ms. Linda Rockett J.D.
Senior VP of Corporate Development & Head of Emerging Areas
Dr. Christopher Francis Ph.D.
Show More
Senior VP & Head of Human Resources
Ms. Daryn Lewis
Senior Vice President of Chemistry, Manufacturing & Controls
Dr. Sridhar Vaddeboina Ph.D.
Chief Development Officer
Ms. Anne-Marie Li-Kwai-Cheung
Senior Vice President of Translational Medicine
Dr. Hsiu-Chiung Yang Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one WVE stock?

The intrinsic value of one WVE stock under the Base Case scenario is 3.27 USD.

Is WVE stock undervalued or overvalued?

Compared to the current market price of 5.01 USD, WAVE Life Sciences Ltd is Overvalued by 35%.